Skip to Content
Merck
CN

SAB1305546

Anti-β-Actin (ACTB) Antibody

mouse monoclonal, 8H10D10

Synonym(s):

ACTB, Actin, cytoplasmic 1, Actin, cytoplasmic 1, N-terminally processed, Beta-actin

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
Clone:
8H10D10, monoclonal
Species reactivity:
human
Application:
IHC, WB
Citations:
5
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

MONOCLONAL ANTI-BETA-ACTIN antibody produced in mouse, clone 8H10D10, IgG fraction of antiserum, buffered aqueous solution

biological source

mouse

Quality Level

antibody form

IgG fraction of antiserum

antibody product type

primary antibodies

clone

8H10D10, monoclonal

form

buffered aqueous solution

mol wt

41737 Da

species reactivity

human

technique(s)

immunohistochemistry: 1:10-1:50, western blot: 1:2000-1:10000

NCBI accession no.

UniProt accession no.

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... ACTB(60)

Application

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Western Blotting (1 paper)

Physical form

Supplied in PBS with 0.09% (W/V) sodium azide

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


Still not finding the right product?

or

Try our Product Selector Tool to narrow your options


Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

常规特殊物品
低风险生物材料

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Eylem Kulkoyluoglu-Cotul et al.
Cancers, 11(4) (2019-04-17)
A majority of breast cancer specific deaths in women with ERα (+) tumors occur due to metastases that are resistant to endocrine therapy. There is a critical need for novel therapeutic approaches to resensitize recurrent ERα (+) tumors to endocrine
Kinga Wrobel et al.
Molecular endocrinology (Baltimore, Md.), 30(10), 1029-1045 (2016-08-18)
Most breast cancer deaths occur in women with recurrent, estrogen receptor (ER)-α(+), metastatic tumors. There is a critical need for therapeutic approaches that include novel, targetable mechanism-based strategies by which ERα (+) tumors can be resensitized to endocrine therapies. The
Eylem Kulkoyluoglu Cotul et al.
Cancers, 12(9) (2020-08-28)
The majority of breast cancer specific deaths in women with estrogen receptor positive (ER+) tumors occur due to metastases that are resistant to therapy. There is a critical need for novel therapeutic approaches to achieve tumor regression and/or maintain therapy



Global Trade Item Number

SKUGTIN
SAB1305546-400UL04061836266646